Melhem Solh

机构：Northside Hospital · ORCID：0000-0003-3766-5623

发表论文 408 篇 · 总被引 6975 次 · h-index 43

代表论文

• Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD –mutated AML (2025 · Blood · 被引 51)
• Haploidentical Bone Marrow Transplantation for Sickle Cell Disease (2025 · NEJM Evidence · 被引 43)
• Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703 (2025 · Blood Advances · 被引 15)
• Phase 2 registrational study of anitocabtagene autoleucel for the treatment of patients with relapsed and/or refractory multiple myeloma: Updated results from iMMagine–1 (2025 · Blood · 被引 12)
• Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia (2025 · Blood Advances · 被引 11)
• Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement (2025 · Blood Advances · 被引 8)